Go Ad-Free
    My Alerts
    Moneycontrol
    Moneycontrol PRO
    Loans
    HomeNewsAarti drugs

    Aarti Drugs

    Jump to
    • Stocks to Watch Today: RIL, HDFC Bank, ICICI Bank, JSW Steel, IDFC First Bank, Dr Reddys Labs, IRCON, Sona Comstar, Anthem Biosciences in focus on 21 July

      Stocks to Watch Today: RIL, HDFC Bank, ICICI Bank, JSW Steel, IDFC First Bank, Dr Reddys Labs, IRCON, Sona Comstar, Anthem Biosciences in focus on 21 July

      Stocks to Watch, 21 July: Stocks like Reliance Industries, HDFC Bank, ICICI Bank, JSW Steel, IDFC First Bank, Dr Reddy's Laboratories, IRCON International, Sona BLW Precision Forgings, Anthem Biosciences, and Spunweb Nonwoven will be in focus on July 21.

    • Aarti Drugs Standalone June 2025 Net Sales at Rs 520.96 crore, up 5.68% Y-o-Y

      Aarti Drugs Standalone June 2025 Net Sales at Rs 520.96 crore, up 5.68% Y-o-Y

    • Aarti Drugs Consolidated June 2025 Net Sales at Rs 590.51 crore, up 6.33% Y-o-Y

      Aarti Drugs Consolidated June 2025 Net Sales at Rs 590.51 crore, up 6.33% Y-o-Y

    • Q4FY25 earnings impact: Aarti Drugs shares up 14% on profit growth, MGL and KEI shares higher up to 4%

      Q4FY25 earnings impact: Aarti Drugs shares up 14% on profit growth, MGL and KEI shares higher up to 4%

      Mahanagar Gas' net profit fell nearly 5 percent YoY to Rs 252 crore in Q4 FY25. This, however, marks a rise of nearly 12 percent from the net profit reported in Q3FY25.

    • Aarti Drugs Standalone March 2025 Net Sales at Rs 622.96 crore, up 11.34% Y-o-Y

      Aarti Drugs Standalone March 2025 Net Sales at Rs 622.96 crore, up 11.34% Y-o-Y

    • Aarti Drugs Consolidated March 2025 Net Sales at Rs 676.76 crore, up 9.16% Y-o-Y

      Aarti Drugs Consolidated March 2025 Net Sales at Rs 676.76 crore, up 9.16% Y-o-Y

    • Stocks to Watch Today: BSE, NLC India, GMDC, GP Petroleums, HPCL, Godrej Consumer, KEI Industries, Paytm, Mahanagar Gas in focus on 7 May

      Stocks to Watch Today: BSE, NLC India, GMDC, GP Petroleums, HPCL, Godrej Consumer, KEI Industries, Paytm, Mahanagar Gas in focus on 7 May

      Stocks to Watch, 07 May: Stocks like eMudhra, KEI Industries, Piramal Enterprises, Aarti Drugs, Aptus Value Housing Finance India, Kansai Nerolac Paints, Shriram Finance, Sun Pharmaceutical Industries, Life Insurance Corporation of India, Prestige Estates Projects, Restaurant Brands Asia, and Gujarat Mineral Development Corporation will be in focus on May 7.

    • Aarti Drugs Consolidated December 2024 Net Sales at Rs 556.60 crore, down 8.14% Y-o-Y

      Aarti Drugs Consolidated December 2024 Net Sales at Rs 556.60 crore, down 8.14% Y-o-Y

    • Aarti Drugs Standalone December 2024 Net Sales at Rs 514.54 crore, down 4.4% Y-o-Y

      Aarti Drugs Standalone December 2024 Net Sales at Rs 514.54 crore, down 4.4% Y-o-Y

    • Aarti Drugs Consolidated September 2024 Net Sales at Rs 598.33 crore, down 6.74% Y-o-Y

      Aarti Drugs Consolidated September 2024 Net Sales at Rs 598.33 crore, down 6.74% Y-o-Y

    • Aarti Drugs Standalone September 2024 Net Sales at Rs 543.09 crore, down 5.96% Y-o-Y

      Aarti Drugs Standalone September 2024 Net Sales at Rs 543.09 crore, down 5.96% Y-o-Y

    • Stock Radar: Bajaj Finance, Aarti Drugs, Shilpa Medicare, CESC, Ola Electric, Diffusion Engineers in focus on Friday

      Stock Radar: Bajaj Finance, Aarti Drugs, Shilpa Medicare, CESC, Ola Electric, Diffusion Engineers in focus on Friday

      Bank of Baroda, Mahindra & Mahindra Financial Services, Avenue Supermarts, Cyient DLM, Refex Industries, Sundaram-Clayton, Reliance Power, Canara Bank, and Unicommerce eSolutions will be in focus on October 4.

    • Aarti Drugs shares trade lower after 7 observations from USFDA

      Aarti Drugs shares trade lower after 7 observations from USFDA

      Aarti Drugs Share Price | The company has received seven inspectional observations in 'Form 483' after USFDA inspected the API manufacturing facility.

    • Stock Radar: Dr Reddys, Mankind, Adani Total Gas, Aarti Drugs, BHEL, HFCL, Vodafone in focus on Monday

      Stock Radar: Dr Reddys, Mankind, Adani Total Gas, Aarti Drugs, BHEL, HFCL, Vodafone in focus on Monday

      Dreamfolks Services, Sterling and Wilson Renewable Energy, Ugro Capital, Aster DM Healthcare, ONGC, Ramco Cements, Tata Steel, Avalon Technologies, and HDFC Bank will also be in focus on September 23.

    • Aarti Drugs Consolidated June 2024 Net Sales at Rs 555.34 crore, down 16% Y-o-Y

      Aarti Drugs Consolidated June 2024 Net Sales at Rs 555.34 crore, down 16% Y-o-Y

    • Aarti Drugs Standalone June 2024 Net Sales at Rs 492.96 crore, down 16.68% Y-o-Y

      Aarti Drugs Standalone June 2024 Net Sales at Rs 492.96 crore, down 16.68% Y-o-Y

    • Fire incident at Aarti Drugs' Maharashtra unit, production disrupted

      Fire incident at Aarti Drugs' Maharashtra unit, production disrupted

      Steps are being taken to restore operations at the unit, which the company said has adequate insurance coverage. The insurer has been informed about the incident, the company added in a statement.

    • Aarti Drugs Consolidated March 2024 Net Sales at Rs 619.99 crore, down 16.49% Y-o-Y

      Aarti Drugs Consolidated March 2024 Net Sales at Rs 619.99 crore, down 16.49% Y-o-Y

    • Aarti Drugs Standalone March 2024 Net Sales at Rs 559.53 crore, down 19.66% Y-o-Y

      Aarti Drugs Standalone March 2024 Net Sales at Rs 559.53 crore, down 19.66% Y-o-Y

    • Aarti Drugs Consolidated December 2023 Net Sales at Rs 605.94 crore, down 8.74% Y-o-Y

      Aarti Drugs Consolidated December 2023 Net Sales at Rs 605.94 crore, down 8.74% Y-o-Y

    • Aarti Drugs Standalone December 2023 Net Sales at Rs 538.21 crore, down 13.96% Y-o-Y

      Aarti Drugs Standalone December 2023 Net Sales at Rs 538.21 crore, down 13.96% Y-o-Y

    • Aarti Drugs Consolidated September 2023 Net Sales at Rs 641.54 crore, down 6.71% Y-o-Y

      Aarti Drugs Consolidated September 2023 Net Sales at Rs 641.54 crore, down 6.71% Y-o-Y

    • Aarti Drugs Standalone September 2023 Net Sales at Rs 577.54 crore, down 7.57% Y-o-Y

      Aarti Drugs Standalone September 2023 Net Sales at Rs 577.54 crore, down 7.57% Y-o-Y

    • Aarti Drugs jumps 4%, partly recoups last two days’ losses

      Aarti Drugs jumps 4%, partly recoups last two days’ losses

      As many as 3.3 lakh shares of Aarti Drugs were traded on the exchanges till afternoon

    • Buy Aarti Drugs; target of Rs 665: Axis Securities

      Buy Aarti Drugs; target of Rs 665: Axis Securities

      Axis Securities is bullish on Aarti Drugs has recommended buy rating on the stock with a target price of Rs 665 in its research report dated July 25 2023.

    Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347